Enrichment Strategies for Systemic Sclerosis-Interstitial Lung Disease Trials

被引：2
|
作者：
Volkmann, Elizabeth R. [1 ]
机构：
[1] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷 / 09期
关键词：
DOUBLE-BLIND; CYCLOPHOSPHAMIDE; TOCILIZUMAB; PLACEBO; ADULTS;
D O I：
10.1164/rccm.202401-0246ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1067 / 1068
页数：2
相关论文
共 50 条
  • [31] Interstitial lung disease and systemic sclerosis
    Launay, D.
    REVUE DE MEDECINE INTERNE, 2016, 37 : A16 - A21
  • [32] Interstitial lung disease in systemic sclerosis
    Bussone, Guillaume
    Mouthon, Luc
    AUTOIMMUNITY REVIEWS, 2011, 10 (05) : 248 - 255
  • [33] Interstitial lung disease in systemic sclerosis
    Mouthon, L.
    Berezne, A.
    Brauner, M.
    Kambouchner, M.
    Guillevin, L.
    Valeyre, D.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : 1035 - 1046
  • [34] Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease
    Landini, Nicholas
    Orlandi, Martina
    Occhipinti, Mariaelena
    Nardi, Cosimo
    Tofani, Lorenzo
    Bellando-Randone, Silvia
    Ciet, Pierluigi
    Wielopolski, Piotr
    Benkert, Thomas
    Bruni, Cosimo
    Bertolo, Silvia
    Moggi-Pignone, Alberto
    Matucci-Cerinic, Marco
    Morana, Giovanni
    Colagrande, Stefano
    JOURNAL OF THORACIC IMAGING, 2023, 38 (02) : 97 - 103
  • [35] Quantitative Computed Tomography in Systemic Sclerosis-Interstitial Lung Disease: Are We Ready to Go beyond Standard Assessment?
    Ariani, Alarico
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (01) : 183 - 184
  • [36] Treatment with Cyclophosphamide for Systemic Sclerosis-Interstitial Lung Disease Does Not Lead to a Sustained Improvement in Lung Function in Two Independent Cohorts
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Sim, Myung
    Li, Ning
    Khanna, Dinesh
    Roth, Michael
    Clements, Philip J.
    Hoffmann-Vold, Anna-Maria
    Furst, Daniel E.
    Kim, Grace
    Goldin, Jonathan
    Elashoff, Robert
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [37] MYCOPHENOLATE MOPHETIL IN THE TREATMENT OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSC-ILD) IN PATIENTS UNRESPONSIVE TO CYCLOPHOSPHAMIDE (CYC)
    Cuomo, G.
    Abignano, G.
    Iudici, M.
    Petrillo, A.
    Valentini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S167 - S167
  • [38] Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
    Di Battista, Marco
    Tavanti, Laura
    Pistelli, Francesco
    Carrozzi, Laura
    Da Rio, Mattia
    Rossi, Alessandra
    Puccetti, Lorenzo
    Tavoni, Antonio
    Romei, Chiara
    Morganti, Riccardo
    Della Rossa, Alessandra
    Mosca, Marta
    INFLAMMOPHARMACOLOGY, 2023, 31 (05) : 2445 - 2449
  • [39] The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
    Lepri, Gemma
    Bruni, Cosimo
    Tofani, Lorenzo
    Moggi-Pignone, Alberto
    Orlandi, Martina
    Tomassetti, Sara
    Hughes, Michael
    Del Galdo, Francesco
    Irace, Rosaria
    Distler, Oliver
    Riccieri, Valeria
    Allanore, Yannick
    Gheorghiu, Ana Maria
    Siegert, Elise
    De Vries-Bouwstra, Jeska
    Hachulla, Eric
    Tikly, Mohammed
    Damjanov, Nemanja
    Spertini, Francois
    Mouthon, Luc
    Hoffmann-Vold, Anna-Maria
    Gabrielli, Armando
    Guiducci, Serena
    Matucci-Cerinic, Marco
    Furst, Daniel
    Bellando-Randone, Silvia
    DIAGNOSTICS, 2024, 14 (03)
  • [40] Reply: Quantitative Computed Tomography in Systemic Sclerosis-Interstitial Lung Disease: Are We Ready to Go beyond Standard Assessment?
    Saldana, Daniela Castillo
    Coxson, Harvey O.
    Ryerson, Christopher J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (01) : 184 - 184
12345